{"id":80679,"date":"2026-05-12T15:08:12","date_gmt":"2026-05-12T15:08:12","guid":{"rendered":"https:\/\/www.europesays.com\/dk\/80679\/"},"modified":"2026-05-12T15:08:12","modified_gmt":"2026-05-12T15:08:12","slug":"novo-nordisk-a-s-trading-in-novo-nordisk-shares-by-board-members-executives-and-associated-persons-3","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/dk\/80679\/","title":{"rendered":"Novo Nordisk A\/S: Trading in Novo Nordisk shares by board members, executives and associated persons"},"content":{"rendered":"<p>Bagsv\u00e6rd, Denmark, 12 May 2026 &#8211; This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company\u2019s board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596\/2014 on market abuse. The company\u2019s board members, executives and their associated persons have reported the transactions to Novo Nordisk.<\/p>\n<p>1 Details of the person discharging managerial responsibilities\/person closely associated a)Name of the Board member\/Executive\/Associated PersonCaroline Munk Esbjerg\u00a02 Reason for the notification\u00a0a)Position\/statusClosely associated person to Karsten Munk Knudsen, Executive Vice President, Chief Financial Officer (CFO)\u00a0b)Initial notification\/AmendmentInitial notification\u00a03 Details of the issuer\u00a0a)NameNovo Nordisk A\/S\u00a0b)LEI549300DAQ1CVT6CXN342\u00a04 Details of the transaction(s)\u00a0a)Description of the financial instrument,<\/p>\n<p>type of instrument,<\/p>\n<p>Shares<\/p>\n<p>\u00a0<\/p>\n<p>Get the latest news<br \/>\n                <br class=\"br-line\"\/><br \/>\n                delivered to your inbox<\/p>\n<p>Sign up for The Manila Times newsletters<\/p>\n<p>            By signing up with an email address, I acknowledge that I have read and agree to the <a href=\"https:\/\/www.manilatimes.net\/terms-of-service\" title=\"Terms of Service\" rel=\"nofollow noopener\" target=\"_blank\">Terms of Service<\/a> and <a href=\"https:\/\/www.manilatimes.net\/privacy-policy\" title=\"Privacy Policy\" rel=\"nofollow noopener\" target=\"_blank\">Privacy Policy<\/a>.<\/p>\n<p>\u00a0\u00a0Identification codeNovo Nordisk B DK0062498333\u00a0b)Nature of the transactionShares received as gift \u00a0\u00a0c)Price(s) and volume(s)\u00a0Price(s)Volume(s)\u00a0\u00a0\u00a0DKK 294.3050\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0d)Aggregated information \u00a0<\/p>\n<p>50 shares<\/p>\n<p>DKK 14,715<\/p>\n<p>\u00a0e)Date of the transaction2026-05-07\u00a0f)Place of the transactionOutside a trading venue\u00a0<\/p>\n<p> 1 Details of the person discharging managerial responsibilities\/person closely associated a)Name of the Board member\/Executive\/Associated PersonSofie Munk Esbjerg\u00a02 Reason for the notification\u00a0a)Position\/statusClosely associated person to Karsten Munk Knudsen, Executive Vice President, Chief Financial Officer (CFO)\u00a0b)Initial notification\/AmendmentInitial notification\u00a03 Details of the issuer\u00a0a)NameNovo Nordisk A\/S\u00a0b)LEI549300DAQ1CVT6CXN342\u00a04 Details of the transaction(s)\u00a0a)Description of the financial instrument,<\/p>\n<p>type of instrument,<\/p>\n<p>Shares<\/p>\n<p>\u00a0<\/p>\n<p> \u00a0\u00a0Identification codeNovo Nordisk B DK0062498333\u00a0b)Nature of the transactionShares received as gift\u00a0\u00a0c)Price(s) and volume(s)\u00a0Price(s)Volume(s)\u00a0\u00a0\u00a0DKK 294.2550\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0d)Aggregated information \u00a0<\/p>\n<p>50 shares<\/p>\n<p>DKK 14,712.50<\/p>\n<p> \u00a0e)Date of the transaction2026-05-07\u00a0f)Place of the transactionOutside a trading venue\u00a0<\/p>\n<p>About Novo Nordisk<\/p>\n<p>Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark.\u00a0Our\u00a0purpose is to drive change to defeat serious chronic diseases built upon our heritage in diabetes.\u00a0We do so by pioneering scientific breakthroughs, expanding access to our medicines,\u00a0and working to prevent and\u00a0ultimately cure\u00a0disease.\u00a0Novo Nordisk employs about\u00a067,900\u00a0people in 80 countries and markets its products in around 170 countries. For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LasE0SQasG-_tIQbBr9LGcdTCzCRLZJFH1syTZW9mDKtlJIX3yr48vnUmDFyKe5P1Jfgl1kIjZr5Z6ScduFbZOyPKCKmTpy9iSUWJ0xlRPg=\" rel=\"nofollow noopener\" target=\"_blank\">novonordisk.com<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FK0pUkclnKdDyGpdf46cFhDwY_XtYw9GQU2WfCDJVzT6DlNd6_Whb_geZ16q4F-7dPNAI0-R26exKl5EjFaiWI2_UtgMOhDZgwl3hU7AiKY=\" rel=\"nofollow noopener\" target=\"_blank\">Facebook<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LxYitN0LngFkown5gKV60eHYpbGSDBGoXRCGE0BIcjWkxfK2Ptrj5iaopZp7SL9sWo4xwS1OHg8poBAbecZvDMfxkAPzEHypZzbfrC3zvIk=\" rel=\"nofollow noopener\" target=\"_blank\">Instagram<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ivz6EQF1mOc-5vb9X5_2_AwiL4EGrQffJnEcwIt7R-BF4q3gY-Sz2YBBM4QyH_-Gyow5VlFmek3RfLq97s1qqQ==\" rel=\"nofollow noopener\" target=\"_blank\">X<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wr9WXHgeL1l5eb8UKbqvK-EO_3hhcYwOE_0YAqEVxFPWiklWf0CHvsr_Hu4Sgeq97ZhQzyCHNFz33W4_g5y1-3rIChi-Fthy6swXDFhdFdP_KCcPqG0BB-uwq6o04lf8\" rel=\"nofollow noopener\" target=\"_blank\">LinkedIn<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7JqXHH0j1bZNXMOzGj03bF6L7fBY2LgsMfeSlmEFB4ox-KVS1j2-B8PVazDT4WlquWre9pLCzAjVoyUFEL1S5DTrdsIdeLJC0pl8yJUB1Fc=\" rel=\"nofollow noopener\" target=\"_blank\">YouTube<\/a><\/p>\n<p>Contacts for further information<\/p>\n<p> Company announcement No 31 \/ 2026<\/p>\n<p>Attachment<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/www.europesays.com\/dk\/wp-content\/uploads\/2026\/05\/1778598492_53_Novo-Nordisk-A-S.png\"\/><\/p>\n","protected":false},"excerpt":{"rendered":"Bagsv\u00e6rd, Denmark, 12 May 2026 &#8211; This company announcement discloses the data of the transaction(s) made in Novo&hellip;\n","protected":false},"author":2,"featured_media":80680,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[271],"tags":[1128,141,6748,6004,1312,6747,216,5349,5691,3845,272,1313,512,6746],"class_list":{"0":"post-80679","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-novo-nordisk","8":"tag-a-s","9":"tag-and","10":"tag-associated","11":"tag-board","12":"tag-by","13":"tag-executives","14":"tag-in","15":"tag-members","16":"tag-nordisk","17":"tag-novo","18":"tag-novo-nordisk","19":"tag-persons","20":"tag-shares","21":"tag-trading"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@dk\/116562238182411619","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/80679","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/comments?post=80679"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/80679\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media\/80680"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media?parent=80679"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/categories?post=80679"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/tags?post=80679"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}